Coronary artery bypass grafting is superior to first-generation drug-eluting stents for unprotected left main coronary artery disease: an updated meta-analysis of 4 randomized, controlled trials

J Thorac Cardiovasc Surg. 2014 Nov;148(5):2430-2. doi: 10.1016/j.jtcvs.2014.08.028. Epub 2014 Aug 19.

Authors

Umberto Benedetto¹, Colin Ng², Robert Smith³, Shahzad G Raja²; Cardiac Outcomes Meta-Analysis (COMET) Group

Affiliations

¹ Department of Cardiac Surgery, Harefield Hospital, London, United Kingdom. Electronic address: umberto.benedetto@hotmail.com.
² Department of Cardiac Surgery, Harefield Hospital, London, United Kingdom.
³ Department of Cardiology, Harefield Hospital, London, United Kingdom.

PMID: 25224547
DOI: 10.1016/j.jtcvs.2014.08.028

No abstract available

Publication types

Meta-Analysis
Review

MeSH terms

Chi-Square Distribution
Coronary Artery Bypass* / adverse effects
Coronary Artery Bypass* / mortality
Coronary Artery Disease / diagnosis
Coronary Artery Disease / mortality
Coronary Artery Disease / surgery
Coronary Artery Disease / therapy*
Drug-Eluting Stents*
Humans
Odds Ratio
Percutaneous Coronary Intervention / adverse effects
Percutaneous Coronary Intervention / instrumentation*
Percutaneous Coronary Intervention / mortality
Prosthesis Design
Randomized Controlled Trials as Topic
Risk Factors
Treatment Outcome